APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cannabinoid Profiling

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cannabinoid Profiling Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchCannabinoid Profiling Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Cannabinoid Profiling Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Cannabinoid Profiling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cannabinoid Profiling Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cannabinoid Profiling Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cannabinoid Profiling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cannabinoid Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cannabinoid Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cannabinoid Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cannabinoid Profiling market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cannabinoid Profiling market include Saskatchewan Research Council (SRC), SC Labs, Steep Hill, SGS Canada, CW ANALYTICAL, PharmLabs, GreenLeaf Lab, Kaycha Holdings and American Clinical Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cannabinoid Profiling market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cannabinoid Profiling and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cannabinoid Profiling revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cannabinoid Profiling market.

Cannabinoid Profiling Segment by Company

Saskatchewan Research Council (SRC)

SC Labs

Steep Hill

SGS Canada

CW ANALYTICAL

PharmLabs

GreenLeaf Lab

Kaycha Holdings

American Clinical Solutions

CannaSafe

Aurum Labs

A&L Canada Laboratories

Royalmount Laboratories

Confidence Analytics

ACT Laboratories

Cannabinoid Profiling Segment by Type

Gas Chromatography

Liquid Chromatography

Cannabinoid Profiling Segment by Application

Cannabis Drug Manufacturers

Cannabis Cultivators/Growers

Research Institutes

Others

Cannabinoid Profiling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cannabinoid Profiling status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cannabinoid Profiling key companies, revenue, market share, and recent developments.

3. To split the Cannabinoid Profiling breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cannabinoid Profiling market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cannabinoid Profiling significant trends, drivers, influence factors in global and regions.

6. To analyze Cannabinoid Profiling competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid Profiling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cannabinoid Profiling industry.

Chapter 3: Detailed analysis of Cannabinoid Profiling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cannabinoid Profiling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cannabinoid Profiling in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cannabinoid Profiling Industry Trends Table 2. Cannabinoid Profiling Industry Drivers Table 3. Cannabinoid Profiling Industry Opportunities and Challenges Table 4. Cannabinoid Profiling Industry Restraints Table 5. Global Cannabinoid Profiling Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cannabinoid Profiling Revenue Share by Company (2021-2026) Table 7. Global Cannabinoid Profiling Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cannabinoid Profiling Key Company Manufacturing Base & Headquarters Table 9. Global Cannabinoid Profiling Company, Product Type & Application Table 10. Global Cannabinoid Profiling Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cannabinoid Profiling by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gas Chromatography Table 15. Significant Companies of Liquid Chromatography Table 16. Global Cannabinoid Profiling Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cannabinoid Profiling Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cannabinoid Profiling Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cannabinoid Profiling Sales Value Share by Type (2021-2026) Table 20. Global Cannabinoid Profiling Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cannabis Drug Manufacturers Table 22. Significant Companies of Cannabis Cultivators/Growers Table 23. Significant Companies of Research Institutes Table 24. Significant Companies of Others Table 25. Global Cannabinoid Profiling Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cannabinoid Profiling Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cannabinoid Profiling Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cannabinoid Profiling Sales Value Share by Application (2021-2026) Table 29. Global Cannabinoid Profiling Sales Value Share by Application (2027-2032) Table 30. Global Cannabinoid Profiling Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cannabinoid Profiling Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cannabinoid Profiling Sales Value Share by Region (2021-2026) Table 33. Global Cannabinoid Profiling Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cannabinoid Profiling Sales Value Share by Region (2027-2032) Table 35. Global Cannabinoid Profiling Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cannabinoid Profiling Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cannabinoid Profiling Sales Value Market Share by Country (2021-2026) Table 38. Global Cannabinoid Profiling Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cannabinoid Profiling Sales Value Market Share by Country (2027-2032) Table 40. Saskatchewan Research Council (SRC) Company Information Table 41. Saskatchewan Research Council (SRC) Business Overview Table 42. Saskatchewan Research Council (SRC) Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio Table 44. Saskatchewan Research Council (SRC) Recent Development Table 45. SC Labs Company Information Table 46. SC Labs Business Overview Table 47. SC Labs Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. SC Labs Cannabinoid Profiling Product Portfolio Table 49. SC Labs Recent Development Table 50. Steep Hill Company Information Table 51. Steep Hill Business Overview Table 52. Steep Hill Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Steep Hill Cannabinoid Profiling Product Portfolio Table 54. Steep Hill Recent Development Table 55. SGS Canada Company Information Table 56. SGS Canada Business Overview Table 57. SGS Canada Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. SGS Canada Cannabinoid Profiling Product Portfolio Table 59. SGS Canada Recent Development Table 60. CW ANALYTICAL Company Information Table 61. CW ANALYTICAL Business Overview Table 62. CW ANALYTICAL Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. CW ANALYTICAL Cannabinoid Profiling Product Portfolio Table 64. CW ANALYTICAL Recent Development Table 65. PharmLabs Company Information Table 66. PharmLabs Business Overview Table 67. PharmLabs Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. PharmLabs Cannabinoid Profiling Product Portfolio Table 69. PharmLabs Recent Development Table 70. GreenLeaf Lab Company Information Table 71. GreenLeaf Lab Business Overview Table 72. GreenLeaf Lab Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GreenLeaf Lab Cannabinoid Profiling Product Portfolio Table 74. GreenLeaf Lab Recent Development Table 75. Kaycha Holdings Company Information Table 76. Kaycha Holdings Business Overview Table 77. Kaycha Holdings Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Kaycha Holdings Cannabinoid Profiling Product Portfolio Table 79. Kaycha Holdings Recent Development Table 80. American Clinical Solutions Company Information Table 81. American Clinical Solutions Business Overview Table 82. American Clinical Solutions Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. American Clinical Solutions Cannabinoid Profiling Product Portfolio Table 84. American Clinical Solutions Recent Development Table 85. CannaSafe Company Information Table 86. CannaSafe Business Overview Table 87. CannaSafe Cannabinoid Profiling Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. CannaSafe Cannabinoid Profiling Product Portfolio Table 89. CannaSafe Recent Development Table 90. Aurum Labs Company Information Table 91. Aurum Labs Business Overview Table 92. Aurum Labs Cannabinoid Profiling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Aurum Labs Cannabinoid Profiling Product Portfolio Table 94. Aurum Labs Recent Development Table 95. A&L Canada Laboratories Company Information Table 96. A&L Canada Laboratories Business Overview Table 97. A&L Canada Laboratories Cannabinoid Profiling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. A&L Canada Laboratories Cannabinoid Profiling Product Portfolio Table 99. A&L Canada Laboratories Recent Development Table 100. Royalmount Laboratories Company Information Table 101. Royalmount Laboratories Business Overview Table 102. Royalmount Laboratories Cannabinoid Profiling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Royalmount Laboratories Cannabinoid Profiling Product Portfolio Table 104. Royalmount Laboratories Recent Development Table 105. Confidence Analytics Company Information Table 106. Confidence Analytics Business Overview Table 107. Confidence Analytics Cannabinoid Profiling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Confidence Analytics Cannabinoid Profiling Product Portfolio Table 109. Confidence Analytics Recent Development Table 110. ACT Laboratories Company Information Table 111. ACT Laboratories Business Overview Table 112. ACT Laboratories Cannabinoid Profiling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. ACT Laboratories Cannabinoid Profiling Product Portfolio Table 114. ACT Laboratories Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Cannabinoid Profiling Product Image Figure 2. Global Cannabinoid Profiling Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cannabinoid Profiling Market Size (2021-2032) & (US$ Million) Figure 4. Global Cannabinoid Profiling Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gas Chromatography Image Figure 8. Liquid Chromatography Image Figure 9. Global Cannabinoid Profiling Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cannabinoid Profiling Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cannabinoid Profiling Sales Value Share by Type (2021-2032) Figure 12. Cannabis Drug Manufacturers Image Figure 13. Cannabis Cultivators/Growers Image Figure 14. Research Institutes Image Figure 15. Others Image Figure 16. Global Cannabinoid Profiling Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cannabinoid Profiling Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cannabinoid Profiling Sales Value Share by Application (2021-2032) Figure 19. Global Cannabinoid Profiling Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cannabinoid Profiling Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cannabinoid Profiling Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cannabinoid Profiling Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cannabinoid Profiling Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cannabinoid Profiling Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cannabinoid Profiling Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cannabinoid Profiling Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cannabinoid Profiling Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cannabinoid Profiling Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cannabinoid Profiling Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cannabinoid Profiling Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cannabinoid Profiling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Gas Chromatography
  • Liquid Chromatography
Applications
  • Cannabis Drug Manufacturers
  • Cannabis Cultivators/Growers
  • Research Institutes
  • Others
Companies covered
  • Saskatchewan Research Council (SRC)
  • SC Labs
  • Steep Hill
  • SGS Canada
  • CW ANALYTICAL
  • PharmLabs
  • GreenLeaf Lab
  • Kaycha Holdings
  • American Clinical Solutions
  • CannaSafe
  • Aurum Labs
  • A&L Canada Laboratories
  • Royalmount Laboratories
  • Confidence Analytics
  • ACT Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cannabinoid Profiling Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cannabinoid Profiling Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cannabinoid Profiling Market Dynamics
  1. 2.1 Cannabinoid Profiling Industry Trends
  2. 2.2 Cannabinoid Profiling Industry Drivers
  3. 2.3 Cannabinoid Profiling Industry Opportunities and Challenges
  4. 2.4 Cannabinoid Profiling Industry Restraints
3 Cannabinoid Profiling Market by Company
  1. 3.1 Global Cannabinoid Profiling Company Revenue Ranking in 2025
  2. 3.2 Global Cannabinoid Profiling Revenue by Company (2021-2026)
  3. 3.3 Global Cannabinoid Profiling Company Ranking (2024-2026)
  4. 3.4 Global Cannabinoid Profiling Company Manufacturing Base and Headquarters
  5. 3.5 Global Cannabinoid Profiling Company Product Type and Application
  6. 3.6 Global Cannabinoid Profiling Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cannabinoid Profiling Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cannabinoid Profiling Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cannabinoid Profiling Market by Type
  1. 4.1 Cannabinoid Profiling Type Introduction
  2. 4.1.1 Gas Chromatography
  3. 4.1.2 Liquid Chromatography
  4. 4.2 Global Cannabinoid Profiling Sales Value by Type
  5. 4.2.1 Global Cannabinoid Profiling Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cannabinoid Profiling Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cannabinoid Profiling Sales Value Share by Type (2021-2032)
5 Cannabinoid Profiling Market by Application
  1. 5.1 Cannabinoid Profiling Application Introduction
  2. 5.1.1 Cannabis Drug Manufacturers
  3. 5.1.2 Cannabis Cultivators/Growers
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Cannabinoid Profiling Sales Value by Application
  7. 5.2.1 Global Cannabinoid Profiling Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cannabinoid Profiling Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cannabinoid Profiling Sales Value Share by Application (2021-2032)
6 Cannabinoid Profiling Regional Value Analysis
  1. 6.1 Global Cannabinoid Profiling Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cannabinoid Profiling Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cannabinoid Profiling Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cannabinoid Profiling Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cannabinoid Profiling Sales Value (2021-2032)
  7. 6.3.2 North America Cannabinoid Profiling Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cannabinoid Profiling Sales Value (2021-2032)
  10. 6.4.2 Europe Cannabinoid Profiling Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cannabinoid Profiling Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cannabinoid Profiling Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cannabinoid Profiling Sales Value (2021-2032)
  16. 6.6.2 South America Cannabinoid Profiling Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cannabinoid Profiling Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cannabinoid Profiling Sales Value Share by Country, 2025 VS 2032
7 Cannabinoid Profiling Country-level Value Analysis
  1. 7.1 Global Cannabinoid Profiling Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cannabinoid Profiling Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cannabinoid Profiling Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cannabinoid Profiling Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cannabinoid Profiling Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cannabinoid Profiling Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cannabinoid Profiling Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Saskatchewan Research Council (SRC)
  2. 8.1.1 Saskatchewan Research Council (SRC) Company Information
  3. 8.1.2 Saskatchewan Research Council (SRC) Business Overview
  4. 8.1.3 Saskatchewan Research Council (SRC) Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio
  6. 8.1.5 Saskatchewan Research Council (SRC) Recent Developments
  7. 8.2 SC Labs
  8. 8.2.1 SC Labs Company Information
  9. 8.2.2 SC Labs Business Overview
  10. 8.2.3 SC Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SC Labs Cannabinoid Profiling Product Portfolio
  12. 8.2.5 SC Labs Recent Developments
  13. 8.3 Steep Hill
  14. 8.3.1 Steep Hill Company Information
  15. 8.3.2 Steep Hill Business Overview
  16. 8.3.3 Steep Hill Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Steep Hill Cannabinoid Profiling Product Portfolio
  18. 8.3.5 Steep Hill Recent Developments
  19. 8.4 SGS Canada
  20. 8.4.1 SGS Canada Company Information
  21. 8.4.2 SGS Canada Business Overview
  22. 8.4.3 SGS Canada Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS Canada Cannabinoid Profiling Product Portfolio
  24. 8.4.5 SGS Canada Recent Developments
  25. 8.5 CW ANALYTICAL
  26. 8.5.1 CW ANALYTICAL Company Information
  27. 8.5.2 CW ANALYTICAL Business Overview
  28. 8.5.3 CW ANALYTICAL Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CW ANALYTICAL Cannabinoid Profiling Product Portfolio
  30. 8.5.5 CW ANALYTICAL Recent Developments
  31. 8.6 PharmLabs
  32. 8.6.1 PharmLabs Company Information
  33. 8.6.2 PharmLabs Business Overview
  34. 8.6.3 PharmLabs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmLabs Cannabinoid Profiling Product Portfolio
  36. 8.6.5 PharmLabs Recent Developments
  37. 8.7 GreenLeaf Lab
  38. 8.7.1 GreenLeaf Lab Company Information
  39. 8.7.2 GreenLeaf Lab Business Overview
  40. 8.7.3 GreenLeaf Lab Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GreenLeaf Lab Cannabinoid Profiling Product Portfolio
  42. 8.7.5 GreenLeaf Lab Recent Developments
  43. 8.8 Kaycha Holdings
  44. 8.8.1 Kaycha Holdings Company Information
  45. 8.8.2 Kaycha Holdings Business Overview
  46. 8.8.3 Kaycha Holdings Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kaycha Holdings Cannabinoid Profiling Product Portfolio
  48. 8.8.5 Kaycha Holdings Recent Developments
  49. 8.9 American Clinical Solutions
  50. 8.9.1 American Clinical Solutions Company Information
  51. 8.9.2 American Clinical Solutions Business Overview
  52. 8.9.3 American Clinical Solutions Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  53. 8.9.4 American Clinical Solutions Cannabinoid Profiling Product Portfolio
  54. 8.9.5 American Clinical Solutions Recent Developments
  55. 8.10 CannaSafe
  56. 8.10.1 CannaSafe Company Information
  57. 8.10.2 CannaSafe Business Overview
  58. 8.10.3 CannaSafe Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CannaSafe Cannabinoid Profiling Product Portfolio
  60. 8.10.5 CannaSafe Recent Developments
  61. 8.11 Aurum Labs
  62. 8.11.1 Aurum Labs Company Information
  63. 8.11.2 Aurum Labs Business Overview
  64. 8.11.3 Aurum Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aurum Labs Cannabinoid Profiling Product Portfolio
  66. 8.11.5 Aurum Labs Recent Developments
  67. 8.12 A&L Canada Laboratories
  68. 8.12.1 A&L Canada Laboratories Company Information
  69. 8.12.2 A&L Canada Laboratories Business Overview
  70. 8.12.3 A&L Canada Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  71. 8.12.4 A&L Canada Laboratories Cannabinoid Profiling Product Portfolio
  72. 8.12.5 A&L Canada Laboratories Recent Developments
  73. 8.13 Royalmount Laboratories
  74. 8.13.1 Royalmount Laboratories Company Information
  75. 8.13.2 Royalmount Laboratories Business Overview
  76. 8.13.3 Royalmount Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Royalmount Laboratories Cannabinoid Profiling Product Portfolio
  78. 8.13.5 Royalmount Laboratories Recent Developments
  79. 8.14 Confidence Analytics
  80. 8.14.1 Confidence Analytics Company Information
  81. 8.14.2 Confidence Analytics Business Overview
  82. 8.14.3 Confidence Analytics Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Confidence Analytics Cannabinoid Profiling Product Portfolio
  84. 8.14.5 Confidence Analytics Recent Developments
  85. 8.15 ACT Laboratories
  86. 8.15.1 ACT Laboratories Company Information
  87. 8.15.2 ACT Laboratories Business Overview
  88. 8.15.3 ACT Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ACT Laboratories Cannabinoid Profiling Product Portfolio
  90. 8.15.5 ACT Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst